<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00957021</url>
  </required_header>
  <id_info>
    <org_study_id>55</org_study_id>
    <nct_id>NCT00957021</nct_id>
  </id_info>
  <brief_title>Triathlon® Posteriorly Stabilized (PS) Total Knee System - Outcomes Study</brief_title>
  <official_title>A Prospective, Post-market, Multi-center Study of the Outcomes of the Triathlon® Posteriorly Stabilized (PS) Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical outcomes (range of motion, pain,
      function, radiographic stability, and health related quality of life) of patients receiving
      the Triathlon® Posterior Stabilized (PS) Total Knee System. These outcomes will be evaluated
      using pre-operative scores and comparing them to post-operative scores in addition to being
      compared with cases who received the Scorpio® PS implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Triathlon® Posteriorly Stabilized (PS) Total Knee System components are for use in
      cemented total knee arthroplasty for painful, disabling joint disease of the knee resulting
      from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic
      arthritis or avascular necrosis) or rheumatoid arthritis (excluded from this study according
      to protocol).

      The components are designed to improve range of motion (ROM) and stability. This study serves
      to demonstrate that subjects have reduced pain, increased ROM and improved stability
      following implantation with the Triathlon® PS Total Knee System.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>2 years</time_frame>
    <description>The primary outcome of this study is to compare active range of motion values for the Triathlon PS Total Knee System.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Outcome Knee Society Score</measure>
    <time_frame>1,2 and 5 years</time_frame>
    <description>The Knee Society Scores (KSS) at 1, 2, and 5-year visits will be compared. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen at each time point. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as &quot;excellent,&quot; &quot;good,&quot; &quot;fair,&quot; or &quot;poor,&quot; a higher value represents a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Outcome SF-36</measure>
    <time_frame>1,2,3,4 and 5 years</time_frame>
    <description>The SF-36 score at 1, 2, 3, 4 and 5-year visits will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The SF-36 includes a physical component and a mental component and is completed by the participant. Physical component and mental component scores were calculated on a scale ranging from 0 to 100. Low values represented a poor health state and high values represented a good health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Outcome WOMAC</measure>
    <time_frame>5 years</time_frame>
    <description>The Western Ontario and McMaster Osteoarthritis Index (WOMAC) scores at 1, 2, 3, 4 and 5-year visits will be compared between groups, when data is available. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen for each time point. The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.
Data for the WOMAC is only available at the 5 year interval due to typographical errors noted on earlier interval forms rendering them invalid for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Outcome Lower-Extremity Activity Scale</measure>
    <time_frame>1,2,3,4 and 5 years</time_frame>
    <description>The Lower-Extremity Activity Scale (LEAS) score at 1, 2, 3, 4 and 5-year intervals will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. A level of 1 indicated that the subject was confined to bed all day while a level of 18 indicated that the subject was up and about at will inside and outside of the house, and also participated in vigorous physical activity, such as competitive level sports, on a daily basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcome</measure>
    <time_frame>1,2 and 5 years</time_frame>
    <description>Radiographic success/failure at 1, 2, and 5-year visits will be assessed. Radiographic failure is defined as a score of 10 or greater according to the Knee Society Roentgenographic Scoring System, regardless of symptoms. A migrating or shifting prosthesis with or without the disappearance of radiolucent lines is also a failure regardless of score.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">409</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>Triathlon® PS Total Knee System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Triathlon® PS Total Knee System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Triathlon® PS Total Knee System</intervention_name>
    <description>Triathlon® PS Total Knee system</description>
    <arm_group_label>Triathlon® PS Total Knee System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is a male or non-pregnant female 21-80 years of age at the time of
             enrollment.

          2. The subject requires a primary cemented total knee replacement.

          3. The subject has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or
             avascular necrosis (AVN).

          4. The subject has intact collateral ligaments.

          5. The subject has signed the IRB approved, study specific Informed Patient Consent Form.

          6. The subject is willing and able to comply with postoperative scheduled clinical and
             radiographic evaluations and rehabilitation.

        Exclusion Criteria:

          1. The subject has inflammatory arthritis.

          2. The subject is morbidly obese, BMI &gt; 40.

          3. The subject has a history of total or unicompartmental reconstruction of the affected
             joint.

          4. The subject has had a high tibial osteotomy or femoral osteotomy.

          5. The subject has a neuromuscular or neurosensory deficiency that would limit the
             ability to assess the performance of the device.

          6. The subject has a systemic or metabolic disorder leading to progressive bone
             deterioration.

          7. The subject is immunologically suppressed, or receiving chronic steroids (&gt;30 days
             duration).

          8. The subject's bone stock is compromised by disease or infection and cannot provide
             adequate support and/or fixation to the prosthesis.

          9. The subject has had a knee fusion at the affected joint.

         10. The subject has an active or suspected latent infection in or about the knee joint.

         11. The subject is a prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric R Benson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New Hampshire Orthopaedic Surgery, PA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Moretta, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tri County Orthopedics Surgeons, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Bono, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New England Baptist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David W Edelstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kelsey-Seybold Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip Ireland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ireland Hip and Knee Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph P Nessler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Cloud Orthopaedic Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Quanjun Cui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnold Scheller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pro-Sports Orthopaedics, Inc./ New England Baptist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joel Sorger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wellington Orthopaedics and Sports Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suresh Nayak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wellington Orthopaedics and Sports Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John I Waldrop, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hughston Clinic, PA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James McGrory, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hughston Clinic, PA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven B Zelicof, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Specialty Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hughston Clinic PA</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ireland Hip and Knee Surgery</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New England Baptist Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pro-Sports Orthopaedics, Inc. / New England Baptist Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02445</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Cloud Orthopaedic Associates</name>
      <address>
        <city>Sartell</city>
        <state>Minnesota</state>
        <zip>56377</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Hampshire Orthopaedic Surgery, PA</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specialty Orthopaedics</name>
      <address>
        <city>Harrison</city>
        <state>New York</state>
        <zip>10528</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellington Orthopaedics &amp; Sports Medicine</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tri County Orthopedic Surgeons, Inc.</name>
      <address>
        <city>Massillon</city>
        <state>Ohio</state>
        <zip>44646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kelsey-Seybold Clinic</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2009</study_first_submitted>
  <study_first_submitted_qc>August 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2009</study_first_posted>
  <results_first_submitted>September 5, 2013</results_first_submitted>
  <results_first_submitted_qc>November 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 5, 2013</results_first_posted>
  <last_update_submitted>November 29, 2016</last_update_submitted>
  <last_update_submitted_qc>November 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>409 participants/500 knees enrolled - 55 participants/65 knees censored = 354 participants/435 knees followed.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Triathlon® PS Total Knee System</title>
          <description>If both knees were replaced, but only one knee completed the study, the participant is counted as completed.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="354"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="237">Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No 2 yr ROM data</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Revised study component by 2 yr visit</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site Termination by the 2 yr visit</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Surgery Cancelled</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Termination due to language issue</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants who were censored protocol violations or who were enrolled, but did not have surgery and age data was not available, are not included in the baseline analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Triathlon® PS Total Knee System</title>
          <description>Participants who were not censored from analysis.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="351"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>For bilateral total knee replacement participants, the age at the time of the initial knee replacement surgery is used.
3 participants did not have demographic data which would allow calculation of age; these participants did not receive the Triathlon® PS Total Knee System and are part of the &quot;surgery cancelled&quot; participant flow category.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.12" spread="8.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="200"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="351"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Range of Motion</title>
        <description>The primary outcome of this study is to compare active range of motion values for the Triathlon PS Total Knee System.</description>
        <time_frame>2 years</time_frame>
        <population>Participants can have both knees replaced. Range of motion is measured for each knee, as such the number of knees evaluated can be greater than the number of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes participants who received the Triathlon® PS Total Knee System. Participants may have bilateral Triathlon® PS Total Knee replacement (TKR), with surgery occurring on different dates. Participants can therefore have a different status for each knee. If one knee has completed the study (i.e. has 2 year ROM data), the participant is counted in the study complete category.</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion</title>
          <description>The primary outcome of this study is to compare active range of motion values for the Triathlon PS Total Knee System.</description>
          <population>Participants can have both knees replaced. Range of motion is measured for each knee, as such the number of knees evaluated can be greater than the number of participants.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="237"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="291"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124" spread="9.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Outcome Knee Society Score</title>
        <description>The Knee Society Scores (KSS) at 1, 2, and 5-year visits will be compared. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen at each time point. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as “excellent,” “good,” “fair,” or “poor,” a higher value represents a better outcome.</description>
        <time_frame>1,2 and 5 years</time_frame>
        <population>Maximum number of knees evaluated at any interval.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes non-censored participants/knees who received the Triathlon PS Total Knee System. Secondary Objectives are reported by knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Outcome Knee Society Score</title>
          <description>The Knee Society Scores (KSS) at 1, 2, and 5-year visits will be compared. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen at each time point. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as “excellent,” “good,” “fair,” or “poor,” a higher value represents a better outcome.</description>
          <population>Maximum number of knees evaluated at any interval.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="340"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain/Motion 1 Yr (N=335)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.77" spread="9.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Motion 1 Yr difference from Baseline (N=333)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.36" spread="16.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 1 Yr (N=340)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.26" spread="15.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 1 Yr difference from Baseline (N=340)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.99" spread="17.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Motion 2 Yr (N=281)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.96" spread="8.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Motion 2 Yr difference from Baseline (N=279)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.76" spread="17.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 2 Yr (N=284)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.38" spread="16.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 2 Yr difference from Baseline (N=284)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.55" spread="18.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Motion 5 Yr (N=230)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.61" spread="7.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain/Motion 5 Yr difference from Baseline (N=229)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.56" spread="16.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 5 Yr (N=232)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.07" spread="20.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Function 5 Yr difference from Baseline (N=232)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.33" spread="22.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>KSS Pain/Motion and Function Score comparison from pre-op to 1, 2 and 5 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Outcome SF-36</title>
        <description>The SF-36 score at 1, 2, 3, 4 and 5-year visits will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The SF-36 includes a physical component and a mental component and is completed by the participant. Physical component and mental component scores were calculated on a scale ranging from 0 to 100. Low values represented a poor health state and high values represented a good health state.</description>
        <time_frame>1,2,3,4 and 5 years</time_frame>
        <population>Maximum number of knees evaluated at any interval.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes non-censored participants/knees who received the Triathlon PS Total Knee System. Secondary Objectives are reported by knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Outcome SF-36</title>
          <description>The SF-36 score at 1, 2, 3, 4 and 5-year visits will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The SF-36 includes a physical component and a mental component and is completed by the participant. Physical component and mental component scores were calculated on a scale ranging from 0 to 100. Low values represented a poor health state and high values represented a good health state.</description>
          <population>Maximum number of knees evaluated at any interval.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="273"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="335"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SF36 Physical Component 1 Yr (N=335)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.16" spread="8.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical 1 Yr difference from Baseline(N=332)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.32" spread="9.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental Component 1 Yr (N=335)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.21" spread="8.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental 1Yr difference from Baseline(N=332)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical Component 2Yr (N=290)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.34" spread="9.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical 2 Yr difference from Baseline(N=288)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.54" spread="9.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental Component 2 Yr (N=290)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.04" spread="8.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental 2Yr difference from Baseline(N=288)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.04" spread="10.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical Component 3Yr (N=259)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.23" spread="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical 3 Yr difference from Baseline(N=257)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.45" spread="9.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental Component 3 Yr (N=259)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.30" spread="9.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental 3 Yr difference from Baseline(N=257)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.93" spread="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical Component 4 Yr (N=254)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.26" spread="10.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical 4 Yr difference from Baseline(N=253)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.58" spread="10.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental Component 4 Yr (N=254)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.49" spread="8.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental 4 Yr difference from Baseline(N=253)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.93" spread="10.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical Component 5 Yr (N=243)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.33" spread="9.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Physical 5 Yr difference from Baseline(N=242)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.65" spread="10.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental Component 5 Yr (N=243)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.82" spread="7.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF36 Mental 5 Yr difference from Baseline(N=242)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Physical score comparison from pre-op to 1, 2, 3, 4 and 5 years</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Mental score comparison from pre-op to 1 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Mental score comparison from pre-op to 2 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0017</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Mental score comparison from pre-op to 3 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0055</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Mental score comparison from pre-op to 4 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0050</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>SF-36 Mental score comparison from pre-op to 5 year</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0018</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Outcome WOMAC</title>
        <description>The Western Ontario and McMaster Osteoarthritis Index (WOMAC) scores at 1, 2, 3, 4 and 5-year visits will be compared between groups, when data is available. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen for each time point. The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.
Data for the WOMAC is only available at the 5 year interval due to typographical errors noted on earlier interval forms rendering them invalid for comparison.</description>
        <time_frame>5 years</time_frame>
        <population>The number of knees evaluated at 5 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes non-censored participants/knees who received the Triathlon PS Total Knee System. Secondary Objectives are reported by knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Outcome WOMAC</title>
          <description>The Western Ontario and McMaster Osteoarthritis Index (WOMAC) scores at 1, 2, 3, 4 and 5-year visits will be compared between groups, when data is available. Additionally, comparison of scores at each post-surgery visit with baseline will be tested to see if any improvement is seen for each time point. The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.
Data for the WOMAC is only available at the 5 year interval due to typographical errors noted on earlier interval forms rendering them invalid for comparison.</description>
          <population>The number of knees evaluated at 5 years.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="197"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.11" spread="53.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Outcome Lower-Extremity Activity Scale</title>
        <description>The Lower-Extremity Activity Scale (LEAS) score at 1, 2, 3, 4 and 5-year intervals will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. A level of 1 indicated that the subject was confined to bed all day while a level of 18 indicated that the subject was up and about at will inside and outside of the house, and also participated in vigorous physical activity, such as competitive level sports, on a daily basis.</description>
        <time_frame>1,2,3,4 and 5 years</time_frame>
        <population>Maximum number of knees available at any interval.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes non-censored participants/knees who received the Triathlon PS Total Knee System. Secondary Objectives are reported by knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Outcome Lower-Extremity Activity Scale</title>
          <description>The Lower-Extremity Activity Scale (LEAS) score at 1, 2, 3, 4 and 5-year intervals will be compared at each post-surgery visit with baseline to see if any improvement is seen for each time point.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. A level of 1 indicated that the subject was confined to bed all day while a level of 18 indicated that the subject was up and about at will inside and outside of the house, and also participated in vigorous physical activity, such as competitive level sports, on a daily basis.</description>
          <population>Maximum number of knees available at any interval.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="274"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="339"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>LEAS 1 Year (N=339)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.22" spread="2.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 1 Year difference from Baseline (N=339)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.97" spread="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 2 Year (N=291)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.04" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 2 Year difference from Baseline (N=291)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 3 Year (N=266)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.15" spread="2.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 3 Year difference from Baseline (N=266)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.95" spread="3.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 4 Year (N=262)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.97" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 4 Year difference from Baseline (N=262)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.87" spread="3.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 5 Year (N=244)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.02" spread="2.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LEAS 5 Year difference from Baseline (N=244)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.89" spread="3.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>LEAS score comparison from pre-op to 1, 2, 3, 4 and 5 years</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Outcome</title>
        <description>Radiographic success/failure at 1, 2, and 5-year visits will be assessed. Radiographic failure is defined as a score of 10 or greater according to the Knee Society Roentgenographic Scoring System, regardless of symptoms. A migrating or shifting prosthesis with or without the disappearance of radiolucent lines is also a failure regardless of score.</description>
        <time_frame>1,2 and 5 years</time_frame>
        <population>Maximum number of knees evaluable at any interval.</population>
        <group_list>
          <group group_id="O1">
            <title>Triathlon® PS Total Knee System</title>
            <description>Includes non-censored participants/knees who received the Triathlon PS Total Knee System. Secondary Objectives are reported by knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Outcome</title>
          <description>Radiographic success/failure at 1, 2, and 5-year visits will be assessed. Radiographic failure is defined as a score of 10 or greater according to the Knee Society Roentgenographic Scoring System, regardless of symptoms. A migrating or shifting prosthesis with or without the disappearance of radiolucent lines is also a failure regardless of score.</description>
          <population>Maximum number of knees evaluable at any interval.</population>
          <units>knees</units>
          <param>Number</param>
          <units_analyzed>knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="345"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Radiographic failure at 1 Yr (N=347 knees)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Radiographic failure at 2 Yrs (N=282 knees)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Radiographic failure at 5 Yrs (N=217 knees)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>This study requires that all operative site and systemic adverse events be reported from enrollment to 5 years postoperative. This includes any change from baseline status. Censored protocol violations were not included as at risk participants.</time_frame>
      <desc>Elective procedures are not included. These may include: non-study total knee/hip replacements/revisions, rotator cuff repairs, carpal tunnel releases, cataract &amp; intra-ocular procedures, bunion procedures, total shoulder repairs, laminectomies, microdiscectomies, breast reductions, cervical spine fusions, &amp; mid-foot/flat-foot surgeries.</desc>
      <group_list>
        <group group_id="E1">
          <title>Triathlon® PS Total Knee System</title>
          <description>All non-censored participants who received the Triathlon® PS Total Knee System.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative site</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative site</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Operative Site</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="354"/>
              </event>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Operative Site</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Operative Site</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="354"/>
              </event>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="19" subjects_affected="16" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="354"/>
              </event>
              <event>
                <sub_title>Operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="194" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="34" subjects_affected="31" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="34" subjects_affected="27" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Operative Site</sub_title>
                <counts group_id="E1" events="121" subjects_affected="90" subjects_at_risk="354"/>
              </event>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="203" subjects_affected="111" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="29" subjects_affected="24" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="30" subjects_affected="22" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="65" subjects_affected="29" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site</sub_title>
                <counts group_id="E1" events="42" subjects_affected="26" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Each investigator shall have privileges for their own center’s results at the completion of the study. These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Research</name_or_title>
      <organization>Stryker Orthopaedics</organization>
      <phone>201-831-5401</phone>
      <email>Ellen.Axelson@Stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

